Latest Angiogenesis Stories
The well-studied protein VEGF does not appear to have any prognostic or predictive value for men with locally advanced prostate cancer.
Injection of human stem cells into mice with tumors slowed down tumor growth.
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.
Combining CT imaging findings with baseline serum lactate dehydrogenase levels is showing promise as a way to predict survival in patients with metastatic melanoma being treated with anti-angiogenic therapy.
- Emitting flashes of light; glittering.